News

Glaxo to Get Up to $200 Million From U.S. for Biothreat Research

June 1, 2013/

GlaxoSmithKline Plc (GSK), the U.K.’s largest drugmaker, will work with the U.S. government to develop antibiotics for resistant infections and bioterrorist threats in an agreement valued at as much as $200 million.

By Makiko Kitamura and Olivia Sterns

Full Story: http://www.businessweek.com/news/2013-05-22/glaxo-to-get-up-to-200-million-from-u-dot-s-dot-for-biothreat-research

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


The Missoula Chamber of Commerce advances the quality of life in Missoula by advocating for a healthy, responsible & diverse business environment & by providing resources that help businesses succeed. Contact Sharon Morren, Director of Membership, [email protected] to join.

MATR Supporters (view all)


Make Your Future in the College of Business

The Great Falls Development Alliance delivers aggressive, award-winning economic development support for business attraction, expansion, and retention.

We will bring the North Coast Hiawatha train route back to Southern Montana